RxDoctor Payments Data

Lawrence Whitney, MD

Vascular & Interventional Radiology · Lakeland, FLNPI 1447439575

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.1%), speaking fees and other — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 57.2% of the total. Reporting peaked in 2024 at $79,226 and has fallen 62.1% since, to $30,004 in 2025. Among vascular & interventional radiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$262,914in general payments, 2019–2025

Across 869 payments — averaging $302.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$150K
  • Penumbra, Inc.$44K
  • Angiodynamics, Inc.$27K
  • Argon Medical Devices, Inc.$11K
  • Inari Medical, Inc.$8K
  • C. R. Bard, Inc. & Subsidiaries$7K
  • plus $16K from 37 others
$87,981in research payments, 2019–2025

Across 55 payments — averaging $1599.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$88K

What the payments were for

  • Consulting fees$126,33848%
  • Speaking & faculty fees$85,45733%
  • Travel & lodging$3,9642%
  • Food & beverage$18,7227%
  • Education$1,7251%
  • Other$26,70810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$262,914 in reported general payments places this provider in the 95th percentile of 329 vascular & interventional radiology providers in Florida.

See all vascular & interventional radiology providers in Florida

Medicare billing

Part B allowed, 2024
$441,360
Medicare patients
291
Services billed
1,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate19$140

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →